Insmed Incorporated (INSM) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Insmed Incorporated
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3…
Source: Yahoo Finance
Sector & Industry
Insmed Incorporated operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Insmed Incorporated at a Glance
| Company | Insmed Incorporated |
| Ticker | INSM |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $126.29 |
| Market cap | $27.58B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$4.12 |
| 52-week high | $212.75 |
| 52-week low | $90.39 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.82 |
| Return on equity (ROE) | -87.22% |
| Debt-to-equity | 97.65% |
| Average volume | 3.28M |
| Shares outstanding | 218.38M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 1,664 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Insmed Incorporated's current P/E ratio?
- Insmed Incorporated (INSM) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Insmed Incorporated's market capitalisation?
- Insmed Incorporated's market cap is $27.58B based on our latest snapshot. See how it ranks by market cap →
- What is INSM's 52-week range?
- Over the past 52 weeks, INSM has traded between $90.39 and $212.75. What does the 52-week range mean? →
- How volatile is Insmed Incorporated compared to the market?
- Insmed Incorporated has a beta of 0.82, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Insmed Incorporated pay a dividend?
- Insmed Incorporated does not currently pay a dividend according to our latest data.
- What exchange is INSM listed on?
- INSM is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Insmed Incorporated in?
- Insmed Incorporated is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →